Dopaminergic drugs

Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase

medication dosage) than the dopaminergic drugs (1). Dopaminergic drugs, although often effective, may have adverse effects such as augmentation (RLS

The medications most commonly prescribed for restless legs syndrome are dopaminergic agents and gabapentin. Dopaminergic drugs alter the activity of

Our results are consistent with a protective effect of dopaminergic Dopaminergic drugs, such as the dopamine precursor L-DOPA; the dopamine

Cabergoline Alternatives Compared ; Drug Class ; Prolactin inhibitors Dopaminergic antiparkinsonism agents Prolactin inhibitors Dopaminergic

classes of antiparkinsonian drugs Several drugs are used for treatment of PD and classified into dopaminergic and nondopaminergic. The dopaminergic drugs include levodopa, dopaminergic agonists (DA), monoamine oxidase-B enzyme (MAO-B) inhibitors, and catechol-ortho-methyltransferase (COMT) inhibitors.

Antiparkinsonian drugs can be classified as dopaminergic and non-dopaminergic drugs. Dopaminergic drugs include levodopa, dopamine agonists, monoamine oxidase

Olanzapine is a new atypical antipsychotic drug which blocks dopaminergic, serotoninergic, antihistaminic, muscarinic, and dopaminergic receptors. From:

Antiparkinsonian drugs can be classified as dopaminergic drugs and non-dopaminergic drugs. Dopaminergic drugs mainly work as modulating dopaminergic transmission. Here the precursor of dopamine, levodopa, dopamine agonists, monoamine oxidase B (MAOB) inhibitors, catechol- O -methyltransferase (COMT) inhibitors, and zonisamide are classified.